3Flühbeck G, Gomez-Ambrosi J, Muruzabal FJ, et al. The adipocyte: a model for integration of endocrine and metabolic signalling in energy metabolism regulation. Am J Physiol Endocrinol Metab, 2001,280:E827-E847.
4Karin M, Cao Y, Greten FR, et al. NF-Kappa B in cancer: from innocent bystander to major culprit. Nat Rev Cancer, 2002, 2:301-310.
5Yang YS, Song HD, Li RY, et al. The gene expression profiling of human visceral adipose tissue and its secretory functions. Biochem Biophys Res Commun, 2003, 300:839-846.
6Wiecek A, Kokot F, Chudek J, et al. The adipose tissue--a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant, 2002,17 : 191-195.
7Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus, lancet, 2003, 361:226-228.
8Kumada M, Kihara S, Sumitsyi S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol, 2003,23:85-89.
9Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol, 2003,148:293-300.
10Earl SF,Wayne HG,William HD,et al.Prevalence of the metabolic syndrome among US adults.JAMA,2002,287:356-359.
